POSSIBILITIES OF USING PROBIOTICS FOR HELICOBACTER PYLORI ERADICATION: MAASTRICHT V CONSENSUS CONFERENCE RECOMMENDATIONS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The new European consensus for the management of patients with Helicobacter pylori (Hp)-associated diseases draws attention to the fact that the stomach has a large number of microorganisms that can influence the development of abnormalities. The use of probiotics contributes to a reduction in the incidence of side effects and enhances the effectiveness of Hp eradication.

全文:

受限制的访问

作者简介

V. Tsukanov

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Professor

E. Kasparov

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Professor

A. Vasyutin

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences

Yu. Tonkikh

Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch of the Russian Academy of Sciences

Email: gastro@impn.ru
Candidate of Medical Sciences

参考

  1. Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection-the Maastricht V / Florence Consensus Report // Gut. - 2017; 66 (1): 6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
  2. Bik E., Eckburg P., Gill S. et al. Molecular analysis of the bacterial microbiota in the human stomach // Proc. Natl. Acad. Sci. USA. - 2006; 103 (3): 732-7.
  3. Cao L., Yu J. Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer // Gastrointest. Tumors. -2015; 2 (1): 14-25.
  4. Khosravi Y., Dieye Y., Poh B. et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients // Sci. World J. - 2014; 2014: 610421.
  5. Sheh A., Fox J. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis // Gut Microbes. - 2013; 4 (6): 505-31.
  6. Буторин Н.Н., Бичурина Т.Б., Цуканов В.В. и др. Распространенность и клинические аспекты пищевода Барретта у населения Восточной Сибири // Тер. арх. - 2013; 1: 62-5.
  7. Цуканов В.В., Третьякова О.В., Амельчугова О.С. и др. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2012; 4: 27-31.
  8. Цуканов В.В., Селиверстова Е.В., Догадин С.А. Показатели липидного состава сыворотки крови и желчи при заболеваниях желчевыводящих путей у больных сахарным диабетом // Тер. арх. - 2005; 2: 15-8.
  9. Агеева Е.С., Штыгашева О.В., Цуканов В.В. и др. Иммунологические особенности течения гастродуоденальной патологии у жителей Хакасии // Иммунология. - 2009; 3: 162-4.
  10. Агеева Е.С., Штыгашева О.В., Рязанцева Н.В. и др. Молекулярногенетические факторы, влияющие на исход инфицирования Helicobacter pylori у жителей Республики Хакасия // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2010; 4: 16-21.
  11. Dicksved J., Lindberg M., Rosenquist M. et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls // J. Med. Microbiol. - 2009; 58 (Pt. 4): 509-16.
  12. Eun C., Kim B., Han D. et al. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods // Helicobacter. - 2014; 19 (6): 407-16.
  13. Lofgren J., Whary M., Ge Z. et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia // Gastroenterology. - 2011; 140 (1): 210-20.
  14. Jernberg C., Löfmark S., Edlund C. et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota // ISME J. - 2007; 1 (1): 56-66.
  15. Ladirat S., Schols H., Nauta A. et al. High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition // J. Microbiol. Methods. - 2013; 92 (3): 387-97.
  16. Engelbrektson A., Korzenik J., Pittler A. et al. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy // J. Med. Microbiol. - 2009; 58 (Pt. 5): 663-70.
  17. Lv Z., Wang B., Zhou X. et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A metaanalysis // Exp. Ther. Med. - 2015; 9 (3): 707-16.
  18. Szajewska H., Horvath A., Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment // Aliment. Pharmacol. Ther. - 2010; 32 (9): 1069-79.
  19. Zhang M., Qian W., Qin Y. et al. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis // World J. Gastroenterol. - 2015; 21 (14): 4345-57.
  20. Marshall B., Warren J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration // Lancet. - 1984; 1 (8390): 1311-5.
  21. Цуканов В.В., Каспаров Э.В., Васютин А.В. и др. Микробиом желудка: развитие революции // Фарматека. - 2016: 15: 78-81.
  22. Sugano K., Tack J., Kuipers E. et al. Kyoto global consensus report on Helicobacter pylori gastritis // Gut. - 2015; 64 (9): 1353-67.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2017
##common.cookie##